|
Home | Current Issue |
Past
Issues | Search | Collections
| PDA Services | Subscribe | Contact Us | Help | ACP Online
|
|
16 January 2001 | Volume 134 Issue 2 | Pages 166-167
Venlafaxine is a new antidepressant drug that inhibits serotonin and norepinephrine reuptake. In clinical trials, venlafaxine was found to be safe and effective (1). However, substantial changes in vital signs (hypertension and hypotension) (2) and cardiac rhythm abnormalities (3) have been observed in a few patients, notably the elderly. We describe a case of venlafaxine-associated conduction disturbances that were reversed after administration of sodium bicarbonate.
A 44-year-old woman took an overdose of venlafaxine (3 g), clonazepam (20 mg), lormetazepam (24 mg), and thioridazine (10 mg). She was intubated and admitted to our medical intensive care unit. Gastric lavage was performed and activated charcoal was administered. The initial electrocardiograph tracing showed a sinus rhythm and incomplete right bundle-branch block (Figure on page 167, top). Two hours later, isotonic saline and norepinephrine were infused because of marked vasoparalysis. Ten hours after admission, a second electrocardiogram (Figure, middle) showed atrial fibrillation with wide QRS complexes. Within 15 minute of infusion of 100 mL of 1 M of sodium bicarbonate, a sinus rhythm with narrow QRS complexes was obtained (Figure, bottom). No further rhythm or conduction abnormality was noted over the following days.
|
A recent report demonstrated that venlafaxine blocks the fast inward sodium current in a concentration-dependent manner in isolated guinea pig ventricular myocytes, thereby promoting membrane-stabilizing effects (4). Our observations support this experimental result and confirm the in vivo efficacy of sodium bicarbonate in reversing the membrane-stabilizing activity of venlafaxine.
Physicians who prescribe antidepressant drugs should be aware of the potential risk associated with venlafaxine, which shares many of the known toxic effects of tricyclic agents. We strongly recommend prolonged surveillance in an intensive care unit for this type of poisoning and the use of alkalinizing agents to treat severe cardiac conduction disturbances.
Author
and Article Information
|
---|
Top Author & Article Info References |
---|
References
|
---|
Top Author & Article Info References |
---|
1. Rudolph RL, Derivan AT. The safety and tolerability of venlafaxine hydrochloride: analysis of the clinical trials database. J Clin Psychopharmacol. 1996;16:54S-59S; discussion 59S-61S. [PMID: 0008784648].
2. Feighner JP. Cardiovascular safety in depressed patients: focus on venlafaxine. J Clin Psychiatry. 1995;56:574-9[PMID: 0008530334].[Medline]
3. Peano C, Leikin JB, Hanashiro PK. Seizures, ventricular tachycardia, and rhabdomyolysis as a result of ingestion of venlafaxine and lamotrigine. Ann Emerg Med. 1997;30:704-8[PMID: 0009360588].[Medline]
4. Khalifa M, Daleau P, Turgeon AJ. Mechanism of
sodium channel block by venlafaxine in guinea pig ventricular myocytes. J
Pharmacol Exp Ther. 1999;291:280-4[PMID: 0010490914].
About Letters
The Editors welcome submissions for possible publication in the
Letters section. Authors of letters should: •Include no more than 300 words of
text, three authors, and five references •Type with double-spacing •Send three
copies of the letter, an authors' form (see Table of Contents for location)
signed by all authors, and a cover letter describing any conflicts of interest
related to the contents of the letter.
Letters
commenting on an Annals article will be considered if they are received
within 6 weeks of the time the article was published. Only some of the letters
received can be published. Published letters are edited and may be shortened;
tables and figures are included only selectively. Authors will be notified that
the letter has been received. If the letter is selected for publication, the
author will be notified about 3 weeks before the publication date. Unpublished
letters cannot be returned.
Annals welcomes
electronically submitted letters. The Internet address is http://www.acponline.org/shell-cgi/letter-article.pl.
|